Drug Repurposing as a Source of Innovative Therapies in Cervical Cancer
Presented at the European Society of Gynaecological Oncology Annual Conference 2021 in Prague
How to capture real-world data to prove efficacy of repurposed drugs?
METRO-PD1: A Phase I Feasibility Study Evaluating Anti-PD1 (NIVOLUMAB) In Combination With Metronomic Chemotherapy In Children And Teenagers With Refractory/Relapsing Solid Tumors Or Lymphoma
Presented at SIOP 2021 Congress
Clinical research in surgical oncology matters
The Anticancer Fund is participating in the World Cancer Series organised by The Economist
Our good cause My Cancer Navigator now supported by Belfius
